论文部分内容阅读
观察新的调节异常血脂药物血脂康治疗高脂血症８４例（其中伴有动脉粥样硬化５６例），对照药为绞股兰片。结果表明．血脂康治疗高脂血症的总显效率为７６．２％．总有效率为９１．７％。与对照组比较差异有非常显著性（Ｐ＜０．００１）。
Observe the new regulatory dyslipidemia Xuezhikang treatment of hyperlipidemia in 84 cases (including atherosclerosis in 56 cases), the control drug for Jiahelan tablets. The results show. Xuezhikang treatment of hyperlipidemia, the total effective rate was 76.2%. The total effective rate was 91.7%. Compared with the control group, the difference was significant (P <0.001).